Financial Year |
March 31 2023 |
Monetary Funds |
645,848,323.86 |
Held-for-trading Financial Assets |
150,370,962.37 |
Notes Receivable |
8,227,638.77 |
Accounts Receivable |
69,625,813.81 |
Advances to Suppliers |
451,316.82 |
Other Receivables |
5,656,378.16 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
74,336,953.83 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
491,283.95 |
Total Current Assets |
1,159,686,207.97 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
-- |
Long-term Equity Investment |
-- |
Investment Properties |
-- |
Fixed Assetes |
6,721,101.91 |
Under-construction Projects |
-- |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
1,198,917.03 |
R&D expenses |
-- |
Goodwill |
-- |
Long-Term Deferred and Prepaid Expenses |
-- |
Deferred Income Tax Assets |
3,730,750.31 |
Other Non-Current Assets |
-- |
Sub-Total of Non-Current Assets |
19,565,488.36 |
Total Assets |
1,179,251,696.33 |
Short-Term Loans |
-- |
Trading Financial liabilities |
-- |
Notes Payable |
17,857,631.09 |
Accounts Payable |
75,091,930.15 |
Accounts Received In Advance |
-- |
Employee Compensation Payable |
37,507,629.61 |
Taxes Payable |
1,627,633.87 |
Interest Payable |
-- |
Dividend Payable |
-- |
Other payables |
2,865,270.54 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
5,259,046.90 |
Other Current Liabilities |
-- |
Sub-Total of Current Liabilities |
144,795,587.65 |
Long-term Loans |
-- |
Bonds Payable |
-- |
Long-Term Accounts Payable |
-- |
Special Payable |
-- |
Estimatied Liabilities |
-- |
Deferred Income Tax Liabilities |
659,855.49 |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
3,259,988.83 |
Total Liabilities |
148,055,576.48 |
Paid-In Capital(Or Share Stock) |
83,297,492.00 |
Capital Surplus |
542,037,955.93 |
Surplus Reserve |
27,971,510.68 |
LESS:Treasury Stock |
-- |
Undistributed Profits |
377,500,454.39 |
Minority Stockholder's Interest |
388,706.85 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,030,807,413.00 |
Owner's Equity(Stockholder's Equity) |
1,031,196,119.85 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
1,179,251,696.33 |